Graft vs Host Disease: all 815 studies
Page 8 of 9. Open to participants first (138), then studies with results posted, then the rest; newest registration first within each.
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesCompletedNCT00438958Phase 3
- Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantCompletedNCT00410657Phase 2
- Thymoglobulin (ATG) Dose Finding StudyTerminatedNCT00409695Phase 1/2
- Alefacept for Chronic Graft Versus Host DiseaseCompletedNCT00397332Phase 1/2
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host DiseaseTerminatedNCT00373815Phase 1
- Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)CompletedNCT00366145Phase 3
- Alefacept for Prevention of Graft Versus Host Disease (GVHD)TerminatedNCT00361413Phase 3
- Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantCompletedNCT00361049Phase 1
- Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantCompletedNCT00357084Phase 2
- Experience of Having Chronic Graft-Versus-Host DiseaseCompletedNCT00353106
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerCompletedNCT00346359Phase 2
- Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host DiseaseStatus unknownNCT00314483Phase 1/2
- Myfortic - Treatment for Extensive cGvHDTerminatedNCT00298324Phase 3
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerTerminatedNCT00290628Not applicable
- Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD ParticipantsCompletedNCT00284986Phase 2
- Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host DiseaseTerminatedNCT00282503Phase 3
- Treatment of Chronic GVHD of Liver or Lungs by ECPStatus unknownNCT00271869Phase 2
- Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00265837Phase 3
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersTerminatedNCT00253552Not applicable
- Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid CancerCompletedNCT00248430Phase 1/2
- Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)CompletedNCT00248365Phase 1/2
- Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHDCompletedNCT00233896Phase 3
- GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host DiseaseCompletedNCT00228839Phase 1
- The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHDStatus unknownNCT00207922
- Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow TransplantationStatus unknownNCT00207792Phase 3
- Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell TransplantationCompletedNCT00201799Phase 2
- Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host DiseaseCompletedNCT00201786Phase 2
- Study Evaluating Sirolimus in Kidney Transplant Recipients in IndiaCompletedNCT00195481Phase 4
- Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking SirolimusCompletedNCT00195468Phase 4
- A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT RecipientsCompletedNCT00189761Phase 2
- A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-CompletedNCT00189748Phase 2
- Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host DiseaseCompletedNCT00186667Phase 2
- High Dose Chemotherapy and Autologous Transplant for Breast CancerCompletedNCT00186641Phase 2
- Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell TransplantationCompletedNCT00180089Phase 3
- Extracorporeal Photopheresis for Acute Graft Versus Host DiseaseCompletedNCT00179855Phase 2/3
- Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell TransplantCompletedNCT00179075
- Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell TransplantCompletedNCT00179049
- Study Evaluating Sirolimus in Kidney Transplant Recipients.CompletedNCT00167947Phase 3
- Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)CompletedNCT00146978Phase 1/2
- Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationCompletedNCT00146614Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNCT00144703Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNCT00144677Phase 2
- Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in ChildrenCompletedNCT00144430Phase 2
- The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host DiseaseCompletedNCT00141713Phase 2
- Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)CompletedNCT00136903Phase 2
- Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host DiseaseCompletedNCT00136396Phase 1/2
- Thymoglobuline in Non-myeloablative Allogeneic Stem-cell TransplantationCompletedNCT00130754Phase 3
- Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell TransplantationCompletedNCT00128739Phase 3
- Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and EverolimusTerminatedNCT00117702Phase 2/3
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
- Cyclosporine Implant for Ocular Graft-Versus-Host DiseaseCompletedNCT00102583Phase 1
- Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00096096Phase 2
- Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaStatus unknownNCT00093587Not applicable
- Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00089037Phase 1/2
- Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell TransplantCompletedNCT00088543Not applicable
- OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic MalignanciesWithdrawnNCT00081055Phase 2
- Recombinant Human Keratinocyte Growth Factor in Unrelated and Related TransplantsCompletedNCT00056875Phase 1/2
- Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal TractCompletedNCT00055666Not applicable
- Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host DiseaseCompletedNCT00054613Phase 2
- Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host DiseaseCompletedNCT00054600Phase 2
- Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative DisorderCompletedNCT00054340Phase 1/2
- Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host DiseaseCompletedNCT00053976Phase 3
- Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaCompletedNCT00053157Not applicable
- Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host DiseaseCompletedNCT00048789Phase 2
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsCompletedNCT00044720Phase 4
- Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host DiseaseCompletedNCT00043147Phase 3
- Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHDTerminatedNCT00038792Phase 1/2
- Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant RecipientsCompletedNCT00037531Phase 3
- Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host DiseaseCompletedNCT00035880Phase 2/3
- Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHDTerminatedNCT00032773Phase 1/2
- Research Study of Visilizumab for Treatment of Acute Graft Versus Host DiseaseCompletedNCT00032292Phase 1/2
- Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host DiseaseStatus unknownNCT00032279Phase 2
- Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host DiseaseCompletedNCT00031824Phase 3
- Keratinocyte Growth Factor to Prevent Acute GVHDCompletedNCT00031148Phase 1/2
- Blood and Marrow Transplant Clinical Research NetworkCompletedNCT00023530Not applicable
- Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek CellsCompletedNCT00023491
- Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic AnemiaStatus unknownNCT00017654Not applicable
- Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerCompletedNCT00014469Phase 2
- Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonCompletedNCT00010283Phase 1/2
- Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver TransplantationCompletedNCT00007059Not applicable
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaCompletedNCT00006747Phase 2
- Bone Marrow Transplantation in Treating Patients With LeukemiaWithdrawnNCT00006451Phase 3
- Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic DisordersStatus unknownNCT00006056Not applicable
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable
- Allogeneic Bone Marrow Transplantation in Patients With Primary ImmunodeficienciesTerminatedNCT00006054Not applicable
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyCompletedNCT00005988Phase 1
- Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow TransplantTerminatedNCT00005852Phase 2
- Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationTerminatedNCT00005641Phase 2
- Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004904Phase 1
- Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid LeukemiaWithdrawnNCT00004878Phase 2
- Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow TransplantationCompletedNCT00004255Phase 2/3
- Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004232Phase 1
- Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host DiseaseStatus unknownNCT00004194Phase 1/2
- Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow TransplantCompletedNCT00003894Phase 2
- Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic DiseasesCompletedNCT00003662Phase 2
- Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003661Phase 2
- Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationCompletedNCT00003538Not applicable
- Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's DiseaseCompletedNCT00003414Phase 3